BioNTech SE (BNTX) Enterprise Value (2018 - 2025)
BioNTech SE (BNTX) posted Enterprise Value of -$20.1 billion for Q4 2025, down 18.54% on a QoQ basis from -$17.0 billion in Q3 2025, and down 12.25% year-over-year from -$22.9 billion in Q4 2024.
BioNTech SE (BNTX) has 8 years of Enterprise Value data on file, last reported at -$20.1 billion in Q4 2025.
- In Q4 2025, Enterprise Value fell 12.25% year-over-year to -$20.1 billion; the TTM figure through Dec 2025 stood at -$20.1 billion (down 12.25% YoY), while the FY2025 annual figure was -$19.5 billion, down 8.95% from the prior year.
- Enterprise Value declined to -$20.1 billion in Q4 2025, from -$17.0 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.4 billion in Q3 2021 and bottomed at -$1459786.9 billion in Q1 2021.
- A 5-year average of -$73096.8 billion and a median of -$16.8 billion in 2023 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 99.87% in 2022, down 563.22% in 2022.
- Year by year, Enterprise Value stood at -$2.4 billion in 2021, then sank by 504.7% to -$14.3 billion in 2022, then slipped by 24.09% to -$17.8 billion in 2023, then declined by 0.73% to -$17.9 billion in 2024, then slipped by 12.25% to -$20.1 billion in 2025.
- The last three Enterprise Value figures came in at -$20.1 billion (Q4 2025), -$17.0 billion (Q3 2025), and -$15.9 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -20.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.32 Bn |
| Sep 30, 2025 | -17.19 Bn |
| Jun 30, 2025 | -15.79 Bn |
| Mar 31, 2025 | -14.40 Bn |
| Dec 31, 2024 | -19.97 Bn |
| Sep 30, 2024 | -20.59 Bn |
| Jun 30, 2024 | -20.01 Bn |
| Mar 31, 2024 | -19.94 Bn |
| Dec 31, 2023 | -20.19 Bn |
| Sep 30, 2023 | -17.87 Bn |
| Jun 30, 2023 | -16.62 Bn |
| Mar 31, 2023 | -15.45 Bn |
| Dec 31, 2022 | -14.35 Bn |
| Sep 30, 2022 | -9.47 Bn |
| Jun 30, 2022 | -6.58 Bn |
| Mar 31, 2022 | -1.95 Bn |
| Dec 31, 2021 | -2.37 Bn |
| Sep 30, 2021 | -1.43 Bn |
| Jun 30, 2021 | -1.46 Bn |
| Mar 31, 2021 | -1,459,786.94 Bn |
| Dec 31, 2020 | -1.61 Bn |
| Dec 31, 2019 | -576.44 Mn |
| Sep 30, 2019 | -515.93 Mn |
| Dec 31, 2018 | -469.10 Mn |
| Sep 30, 2018 | -200.18 Mn |